Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on Roniciclib PK in Advanced Solid Tumors
NCT02457351Phase 1Completed
- Sponsor
- Bayer
- Start
- Jul 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of roniciclib in solid tumor (advanced stage), sponsored by Bayer. Primary endpoints: Maximum observed drug concentration and Area under the concentration vs. time curve. Started Jul 2015; status: completed.
02
Drugs
roniciclib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT02457351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457351.